Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ENB003 |
Trade Name | |
Synonyms | ENB-003|ENB 003|Vodudeutentan Sodium |
Drug Descriptions |
ENB003 is an an antagonist that selectively binds to endothelin B receptor (ETBR) and inhibits downstream signaling, which potentially relieves tumor immunosuppression and inhibits proliferation of tumor cells expressing ETBR (Clin Cancer Res 2009;15(14):4521-4528; NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 2364572-10-9 |
NCIT ID | C175447 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ENB003 | ENB003 | 0 | 0 |
ENB003 + Pembrolizumab | ENB003 Pembrolizumab | 0 | 1 |